Gilead Sciences (GILD) dividend
Gilead Sciences (GILD) reported dividends of $2.84 per share in fiscal 2021 (the year ended December 31, 2021). That is 4.4% higher than the $2.72 of fiscal 2020. Figures as of 19 Nov 2026, 09:15 UTC, from the company's filings with the SEC and Yahoo Finance.
Key facts
- Dividend per share, fiscal 2021
- $2.84
- Change on fiscal 2020
- +4.4%
- Growth, 5 years
- +9.1% a year
- Highest on record
- $2.84fiscal 2021
- Lowest on record
- $0.00fiscal 2013
- Fiscal years on record
- 92013–2021
Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.
Gilead Sciences dividend, in more detail
The market data feed puts the dividend today at $3.28 a share a year.
Over the five fiscal years to 2021 the dividend per share grew at a compound 9.1% a year. Across the 9 fiscal years on record (2013–2021), the highest was $2.84 in fiscal 2021 and the lowest $0.00 in fiscal 2013.
Dividends paid took 33.4% of free cash flow in fiscal 2021. At the share price on the fiscal 2021 year-end that was a yield of 3.9%. The market data feed puts the dividend yield today at 1.9%.
Dividend per share by fiscal year
Gilead Sciences dividend, year by year
| Fiscal year | Dividend per share | Change | Year ended | Share of free cash flow | Yield at year-end |
|---|---|---|---|---|---|
| 2025 | — | — | 42.3% | — | |
| 2024 | — | — | 38.0% | — | |
| 2023 | — | — | 51.3% | — | |
| 2022 | — | — | 44.5% | — | |
| 2021 | $2.84 | 4.4% up | 33.4% | 3.9% | |
| 2020 | $2.72 | 7.9% up | 45.9% | 4.7% | |
| 2019 | $2.52 | 10.5% up | 38.7% | 3.9% | |
| 2018 | $2.28 | 9.6% up | 39.7% | 3.6% | |
| 2017 | $2.08 | 13.0% up | 24.2% | 2.9% | |
| 2016 | $1.84 | 42.6% up | 15.1% | 2.6% | |
| 2015 | $1.29 | — | 9.1% | 1.3% | |
| 2014 | $0.00 | — | 0.0% | 0.0% | |
| 2013 | $0.00 | — | 0.0% | 0.0% |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
Dividend per share is the cash dividend for the fiscal year as the company reports it, re-based for later stock splits; the payout column divides total dividends paid by free cash flow, and the yield column divides the dividend by the closing price at the fiscal year-end.
How to read it
A dividend that grows while taking a modest share of free cash flow is well covered; one that takes more than the business generates is being paid from savings or borrowing.
Dividend per share at health care companies of similar size
| Company | Dividend per share | Fiscal year |
|---|---|---|
| Thermo Fisher Scientific TMO | $1.04 | 2021 |
| Amgen AMGN | $7.22 | 2021 |
| Gilead Sciences GILD | $2.84 | 2021 |
| Abbott Laboratories ABT | $1.92 | 2011 |
| Pfizer PFE | $1.57 | 2021 |
The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.
Gilead Sciences, figure by figure
- Gilead Sciences market cap
- Gilead Sciences revenue
- Gilead Sciences earnings
- Gilead Sciences earnings per share (EPS)
- Gilead Sciences P/E ratio
- Gilead Sciences P/S ratio
- Gilead Sciences P/B ratio
- Gilead Sciences free cash flow
- Gilead Sciences operating margin
- Gilead Sciences shares outstanding
- Gilead Sciences total debt
- Gilead Sciences cash on hand
- Gilead Sciences total assets
- Gilead Sciences total liabilities
- Gilead Sciences net assets (shareholders' equity)
- Gilead Sciences return on equity (ROE)
- Gilead Sciences return on invested capital (ROIC)
Gilead Sciences (GILD) overview: price, valuation and scorecardAll health care companies by market value
Gilead Sciences dividend: questions and answers
What is Gilead Sciences's dividend per share?
Gilead Sciences (GILD) reported dividends of $2.84 per share in fiscal 2021 (the year ended December 31, 2021). That is 4.4% higher than the $2.72 of fiscal 2020. The market data feed puts the dividend today at $3.28 a share a year.
What is the growth rate of Gilead Sciences's dividend per share?
Over the five fiscal years to 2021 the dividend per share grew at a compound 9.1% a year.
What are the highest and lowest dividend per share figures on record for Gilead Sciences?
Across the 9 fiscal years on record (2013–2021), the highest was $2.84 in fiscal 2021 and the lowest $0.00 in fiscal 2013.
Is Gilead Sciences's dividend covered by free cash flow?
Dividends paid took 33.4% of free cash flow in fiscal 2021. At the share price on the fiscal 2021 year-end that was a yield of 3.9%. The market data feed puts the dividend yield today at 1.9%.
How is Gilead Sciences's dividend per share calculated?
Dividend per share is the cash dividend for the fiscal year as the company reports it, re-based for later stock splits; the payout column divides total dividends paid by free cash flow, and the yield column divides the dividend by the closing price at the fiscal year-end. For Gilead Sciences it is on record here for 9 fiscal years, 2013 to 2021.
Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.
Learn: dividend
All stocks guides →- Free cash flow and FCF yield explained
Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.
- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
Cite this page
Funkfolio, “Gilead Sciences (GILD) dividend”, data as of 19 November 2026. https://funkfolio.com/stock/GILD/dividend
Underlying data: the company's filings with the SEC and Yahoo Finance.